Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

ClinicalTrials.gov ID: NCT00672139

Public ClinicalTrials.gov record NCT00672139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Extension Study To Assess The Safety Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Subjects With Advanced Illness And Opioid-Induced Constipation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, multicenter extension of study 3200K1-4000-WW that will evaluate the safety of methylnaltrexone. This drug will be administered by subcutaneous injection and will be tested in late stage, advanced illness patients who have constipation caused by opioid pain relievers. This study will last 3 months.

Study identification

NCT ID
NCT00672139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
156 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2008 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
May 2013 (Actual)
Last update posted
Mar 7, 2018

2008 – 2013

United States locations

U.S. sites
26
U.S. states
11
U.S. cities
23
Facility City State ZIP Site status
Salix Investigational Site Mobile Alabama 36604 —
Salix Investigational Site Laguna Hills California 92637 —
Salix Investigational Site Lancaster California 93534 —
Salix Investigational Site Aurora Colorado 80045 —
Salix Investigational Site Auburndale Florida 33823 —
Salix Investigational Site Hudson Florida 34667 —
Salix Investigational Site Lakeland Florida 33805 —
Salix Investigational Site Lakeland Florida 33815 —
Salix Investigational Site Miami Springs Florida 33166 —
Salix Investigational Site Ruskin Florida 33573 —
Salix Investigational Site Sebring Florida 33870 —
Salix Investigational Site Tampa Florida 33609 —
Salix Investigational Site Tampa Florida 33612-9416 —
Salix Investigational Site Tampa Florida 33619 —
Salix Investigational Site Temple Terrace Florida 33617 —
Salix Investigational Site Orange New Jersey 07018 —
Salix Investigational Site Flat Rock North Carolina 28731 —
Salix Investigational Site Winston-Salem North Carolina 27103-5766 —
Salix Investigational Site Cleveland Ohio 44119 —
Salix Investigational Site Philadelphia Pennsylvania 19111 —
Salix Investigational Site Austin Texas 78757 —
Salix Investigational Site Houston Texas 77030 —
Salix Investigational Site American Fork Utah 84003 —
Salix Investigational Site Orem Utah 84058 —
Salix Investigational Site Provo Utah 84604 —
Salix Investigational Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00672139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →